Skip to Main Content

Paper Details

IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia.
Nat Cancer
16
2022
(, AML, Acute myeloid leukemia, IKAROS, IKAROS protein, IKZF1, KMT2A, MEIS1, MENIN, MLL, MLL)1, MLL-r acute myeloid leukemia, MLL1, chromatin, homeobox (HOX)A10, human, imide, leukemia, leukemia cells, leukemogenic, leukemogenic gene, leukemogenic transcriptional networks, tumor
Author NameAffiliation
Charlie HattonDana-Farber Cancer Institute
Qian ZhuDana-Farber Cancer Institute
Qian ZhuBoston Children's Hospital
Yana PikmanDana-Farber Cancer Institute
Yana PikmanBoston Children's Hospital
Gerard M McGeehanSyndax Pharmaceuticals
Kimberly StegmaierDana-Farber Cancer Institute
Kimberly StegmaierThe Broad Institute of MIT and Harvard
Kimberly StegmaierBoston Children's Hospital
Kimberly StegmaierDana-Farber Cancer Institute
Kimberly StegmaierBoston Children's Hospital
Kimberly StegmaierThe Broad Institute of MIT and Harvard
Xiaole Shirley LiuDana-Farber Cancer Institute
Xiaole Shirley LiuCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Scott A ArmstrongDana-Farber Cancer Institute
Scott A ArmstrongBoston Children's Hospital
Scott A ArmstrongDana-Farber Cancer Institute
Scott A ArmstrongBoston Children's Hospital
  • 1 - 18

Datasets

Release 1.2